Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H24Cl2N10.2ClH |
| Molecular Weight | 548.299 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.ClC1=CC=C(NC(=N)NC(=N)N2CCN(CC2)C(=N)NC(=N)NC3=CC=C(Cl)C=C3)C=C1
InChI
InChIKey=VJVSCTKGPDDOBN-UHFFFAOYSA-N
InChI=1S/C20H24Cl2N10.2ClH/c21-13-1-5-15(6-2-13)27-17(23)29-19(25)31-9-11-32(12-10-31)20(26)30-18(24)28-16-7-3-14(22)4-8-16;;/h1-8H,9-12H2,(H4,23,25,27,29)(H4,24,26,28,30);2*1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C20H24Cl2N10 |
| Molecular Weight | 475.378 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Picloxydine is a heterocyclic biguanide with antibacterial and antiplaque activity. 0.4% Picloxydine produces a highly significant drop in the number of aerobic organisms. 0.4% Picloxydine is far more effective than 0.2% Picloxydine or chlorhexidine in reducing the total viable count of oral aerobic and anaerobic organisms. It is used to treat superficial eye infections. Picloxydine is also used in eye drops in the topical therapy of trachoma. This drug can cause side effects - local intolerance reactions (temporary irritation, allergic reactions).
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:05:12 GMT 2025
by
admin
on
Mon Mar 31 21:05:12 GMT 2025
|
| Record UNII |
WZK4CO345V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
WZK4CO345V
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
19803-62-4
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
m8780
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | Merck Index | ||
|
148548
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
243-328-1
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
20055534
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
100000092639
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
SUB03813MIG
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY | |||
|
DTXSID70941618
Created by
admin on Mon Mar 31 21:05:12 GMT 2025 , Edited by admin on Mon Mar 31 21:05:12 GMT 2025
|
PRIMARY |